Surgery Partners (SGRY) Net Equity Issued and Repurchased (2021 - 2022)
Surgery Partners' (SGRY) quarterly Net Equity Issued and Repurchased came in at $882.9 million in Q4 2022, up 175.13% year-over-year from $320.9 million in Q4 2021, and up 175.13% quarter-over-quarter from $320.9 million in Q4 2021.
Powered by 
Analysis
Surgery Partners (SGRY) Net Equity Issued and Repurchased (2021 - 2022) Analysis & Trends
Surgery Partners has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $882.9 million for Q4 2022.
- In Q4 2022, Net Equity Issued and Repurchased rose 175.13% year-over-year to $882.9 million; the TTM figure through Dec 2022 stood at $882.9 million (up 51.75% YoY), while the FY2022 annual figure was $882.9 million, up 51.75% from the prior year.
- Net Equity Issued and Repurchased came in at $882.9 million for Q4 2022 at Surgery Partners, up from $320.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $882.9 million in Q4 2022 to a low of $260.9 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | - |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | - |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | - |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | - |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 1.07 Mn |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | - |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | - |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | - |
| 10 | Evolent Health | 468.17 Mn | 326.71 Mn | 80.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 882.90 Mn |
| Dec 31, 2021 | 320.90 Mn |
| Mar 31, 2021 | 260.90 Mn |